AbbVie Q3 2026 revenue and earnings soar

Statements (10 of 13)

1. ▲ Bullish

   AbbVie raised full-year net revenue guidance to $67.8 billion

   nasdaq.comOct 31, 2026 14:51 UTCHigh importance
2. ▲ Bullish

   AbbVie's adjusted earnings per share nearly doubled following its latest earnings report

   nasdaq.comOct 31, 2026 14:37 UTCHigh importance
3. ▲ Bullish

   AbbVie raised its full-year profit expectations after third-quarter results exceeded analyst forecasts.

   portfolio.huOct 30, 2026 14:12 UTCHigh importance
4. ● Neutral

   AbbVie Q3 2026 revenue rose 10.3% year on year to $17.4 billion

   barchart.comOct 30, 2026 13:37 UTCHigh importance
5. ● Neutral

   AbbVie posted Q3 2026 sales in line with Wall Street estimates

   barchart.comOct 30, 2026 13:37 UTC
6. ▲ Bullish

   AbbVie reported third-quarter revenue that exceeded analyst forecasts

   investors.comOct 30, 2026 12:47 UTCHigh importance
7. ▲ Bullish

   AbbVie boosted its profit outlook for the year

   wsj.comOct 30, 2026 12:00 UTCHigh importance
8. ▲ Bullish

   AbbVie raised its quarterly dividend

   wsj.comOct 30, 2026 12:00 UTCHigh importance
9. ▲ Bullish

   AbbVie's full-year guidance exceeded expectations

   wsj.comOct 30, 2026 12:00 UTCHigh importance
10. ▲ Bullish

    AbbVie's third-quarter diluted EPS increased over 100 percent year over year.

    prnewswire.comOct 30, 2026 11:46 UTCHigh importance

3 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=c855584c-181f-49fc-abbf-1446efb050e6 Get a free API key ↗